A clinical photograph of a multi-place hyperbaric oxygen therapy (HBOT) or diving chamber, used for treating decompression sickness ('the bends') and conducting respiratory research. The image depicts a large, cylindrical pressure vessel with rounded ends, featuring multiple circular observation portholes and an entry hatch. It is mounted on a heavy-duty metal support frame. Adjacent to the chamber is a vertical control console operated by a clinician. The console is equipped with large analog pressure gauges, flow meters, and valves used to monitor and regulate simulated depth, atmospheric pressure, and gas mixtures within the chamber. The setup illustrates the technology required for hyperbaric medicine and physiological testing at high ambient pressures. Historically located at the Royal Victoria Hospital (Royal Vic), this equipment represents an essential tool in respiratory physiology and the clinical management of gas embolism and nitrogen narcosis.

This clinical photograph displays a monoplace hyperbaric oxygen therapy (HBOT) chamber, a specialized medical device used to deliver 100% oxygen at pressures greater than sea level. The unit features a large, transparent acrylic cylindrical pressure hull, allowing for continuous visual monitoring of a single patient. The chamber's base is a white-enameled metal frame (branded 'PERRY') equipped with a comprehensive integrated control console. This panel includes analog pressure gauges, a digital display screen, manual control valves, and a communication handset for patient-operator interaction. To the left, a mobile computer workstation is positioned for data logging and session monitoring. This equipment is primarily utilized in wound care, emergency medicine, and hyperbaric medicine departments for treating conditions such as chronic non-healing ulcers (e.g., diabetic foot ulcers), decompression sickness, and carbon monoxide poisoning. The setup illustrates the standard clinical environment for administering adjunctive hyperbaric therapy.

A clinical photograph of a multiplace hyperbaric oxygen chamber (HBOT), showcasing its external structure in a hospital setting. The chamber is a large, white, horizontally oriented cylinder constructed from 12mm thick steel. The image displays the entrance with a heavy-duty, hinged pressure door swung inward, featuring a small circular viewing porthole and a horizontal locking handle. Along the lateral side of the vessel, several small, circular methacrylate windows are visible, which serve for patient observation and wireless signal transmission. External hardware, including pressure-rated valves and bolted circular port interfaces, are mounted on the steel hull. The chamber is designed to accommodate multiple patients simultaneously, allowing for the delivery of pure oxygen at pressures higher than atmospheric levels. This specialized medical device is used for treating conditions such as decompression sickness, carbon monoxide poisoning, and non-healing diabetic wounds. The floor consists of clinical-grade tiling, and the chamber occupies a dedicated therapeutic bay.

Clinical photograph of a multiplace hyperbaric oxygen therapy (HBOT) chamber, identified as a Haux Starmed 2200 model, located within a specialized medical facility. The chamber is a large, cylindrical, pressure-sealed vessel designed for delivering oxygen at pressures higher than atmospheric levels. The exterior features a dual-color scheme with a white front-facing entrance panel and a grey longitudinal hull. The entrance consists of a reinforced doorway revealing an illuminated interior with green patient seating. Circular, thick-paned pressure windows (portholes) are distributed along the side for patient monitoring. External safety signage, including red 'prohibition' symbols (likely for fire hazards or smoking), is visible near the entry point. The unit is supported by heavy-duty white rectangular structural blocks on a tiled clinical floor. Such devices are used in the management of conditions like Sudden Sensorineural Hearing Loss (SSNHL), chronic non-healing wounds, and decompression sickness, where hyperbaric oxygen serves to increase plasma-dissolved oxygen and modulate oxidative stress markers.

Clinical photograph of a patient receiving treatment inside a multi-place hyperbaric oxygen therapy (HBOT) chamber. The patient is shown in a seated, semi-reclined position wearing a tight-fitting oronasal oxygen mask connected to a blue corrugated delivery circuit. This setup facilitates the delivery of high-concentration oxygen under increased atmospheric pressure. The interior of the chamber features specialized medical seating, integrated digital monitoring screens labeled with station numbers, and wall-mounted gas delivery ports. Clinical context indicates this therapy is being utilized to manage peripheral neuropathy secondary to nitrous oxide (N2O) neurotoxicity. The image illustrates the application of hyperbaric medicine in treating neurological sequelae by increasing plasma oxygen solubility to counteract tissue hypoxia and potentially modulate cerebral blood flow and metabolic dysfunction caused by chemical inhalation.

This clinical photograph displays an infant undergoing hyperbaric oxygen therapy (HBOT). The patient is positioned inside a specialized pediatric hyperbaric oxygen chamber, which is characterized by a transparent, cylindrical acrylic hull that allows for continuous visual monitoring by medical staff. The chamber is supported by a white structural frame with longitudinal metal reinforcement bars visible. The infant is supine on pink and white bedding, wearing a red patterned onesie and diaper. Visible medical monitoring includes a pulse oximetry sensor attached to the finger to track oxygen saturation during treatment. An identification or monitoring band is also present on the infant's ankle. This device is used in pediatric care to deliver high-pressure oxygen, often utilized in clinical scenarios such as tissue ischemia, complex wound healing, or carbon monoxide poisoning. The setup demonstrates the integration of neonatal intensive care monitoring within a pressurized therapeutic environment.

A clinical photograph of a multi-place hyperbaric oxygen therapy (HBOT) or diving chamber, used for treating decompression sickness ('the bends') and conducting respiratory research. The image depicts a large, cylindrical pressure vessel with rounded ends, featuring multiple circular observation portholes and an entry hatch. It is mounted on a heavy-duty metal support frame. Adjacent to the chamber is a vertical control console operated by a clinician. The console is equipped with large analog pressure gauges, flow meters, and valves used to monitor and regulate simulated depth, atmospheric pressure, and gas mixtures within the chamber. The setup illustrates the technology required for hyperbaric medicine and physiological testing at high ambient pressures. Historically located at the Royal Victoria Hospital (Royal Vic), this equipment represents an essential tool in respiratory physiology and the clinical management of gas embolism and nitrogen narcosis.

This composite of clinical photographs illustrates the dynamics of intravascular bubbles at an active hydrophobic spot (AHS) on a pulmonary vein, relevant to the pathophysiology of decompression sickness. Panel (a) presents a longitudinal series from 0 to 7 minutes post-decompression, showing a stable cluster of spherical bubbles that demonstrates gradual expansion in volume over time. Panel (b) provides a high-speed sequence showing the detachment of a large bubble (indicated by an arrow) from the vessel wall between -2 and -1 seconds, leaving behind a cleared footprint on the tissue surface. Panel (c) captures the process of coalescence at 54 to 55 seconds, where two adjacent smaller bubbles merge into a single larger bubble. The images highlight key educational concepts in diving medicine and hyperbaric physiology, specifically bubble formation (nucleation), growth via gas diffusion, and mechanical detachment into the bloodstream. A 5 mm scale bar is provided for reference.

This composite educational image illustrates the pathophysiology of decompression sickness (DCS). Panels A and B present echocardiographic images (parasternal short-axis view at the aortic root level). Panel A shows normal anatomy including the Aorta (AO), Right Ventricular Outflow Tract (RVOT), Pulmonary Artery (PA), and Right Pulmonary Artery (RPA). Panel B demonstrates the presence of circulating venous gas emboli, visible as hyperechoic, bright punctate 'bubbles' within the RVOT and PA. Panel C is a line graph showing the temporal decline of bubble scores over a 6-hour post-decompression period. Panels D, E, and F are scatter plots with linear regression analysis demonstrating the clinical correlation between bubble load and cutaneous manifestations of DCS. These charts show that higher bubble scores correlate with larger skin lesion areas (r=0.76), shorter latency to the onset of Stage III lesions (r=-0.83), and longer duration of severe skin symptoms (r=0.79). The material serves to teach the relationship between intravascular gas formation and the severity of systemic DCS symptoms.

This composite of clinical photographs illustrates various presentations of Livedo racemosa (LRC) in the context of decompression illness (DCI). The images show affected skin on the upper arms, trunk, and back, characterized by a persistent, reddish-blue to violaceous mottling. The lesion morphology is defined by an irregular, 'broken' net-like or reticulated pattern that does not form complete circles, distinguishing it from livedo reticularis. These manifestations represent cutaneous decompression illness, where vascular occlusion by nitrogen gas bubbles or secondary microthrombi leads to focal perfusion deficiencies and venous congestion. The distribution is typically asymmetrical and can involve the limbs and trunk. Clinically, this sign is significant as it often correlates with a high prevalence of right-to-left shunts, such as a patent foramen ovale (PFO), in diving-related injuries.

This diagnostic image is a B-mode apical four-chamber trans-thoracic echocardiogram (TTE) demonstrating the presence of venous gas emboli (VGE). The visual focuses on the right-sided heart chambers (right atrium and right ventricle), highlighted by an orange dashed ellipse. Within these chambers, numerous discrete, punctate, hyper-echoic signals are visible circulating against the dark, anechoic background of the blood pool. These bright spots represent intravascular gas bubbles, often monitored using the Eftedal-Brubakk (EB) scale in decompression sickness research and diving medicine. The contrast between the hyper-echoic VGE and the relatively echo-free blood pool allows for the quantification of bubble load. The anatomical structures, including the interventricular and interatrial septa and valve leaflets, provide the structural context for identifying the venous side of the heart. This image is used educationally to demonstrate the ultrasound appearance of circulating gas emboli and the application of cardiac imaging in physiological monitoring.

This diagnostic echocardiogram shows a side-by-side comparison of a cardiac four-chamber view used to evaluate venous gas emboli (VGE). Panel A (Raw Image) displays standard anatomical landmarks including the Right Ventricle (RV), Right Atrium (RA), Left Ventricle (LV), Left Atrium (LA), and the tricuspid valve leaflets. Panel B (With Analysis) demonstrates a specialized bubble counting technique where numerous hyperechoic bright spots representing circulating bubbles are identified and circled within the right heart chambers. The educational focus is on distinguishing transient venous gas emboli—often associated with decompression sickness—from fixed cardiac structures such as the tricuspid annulus or papillary muscles. The image is taken from a fifth intercostal space probe placement and includes clinical metadata such as heart rate and count (32 Bubbles). This visual is highly relevant for diving medicine, cardiology, and hyperbaric physiology to illustrate the quantification of post-dive bubble formation.

A clinical photograph of the Masimo Rad-57 Pulse CO-Oximeter, a handheld diagnostic device designed for the non-invasive measurement of carboxyhemoglobin (SpCO) and peripheral oxygen saturation (SpO2). The device is encased in a protective red rubberized sleeve and features a prominent LCD digital display. The screen currently indicates a carboxyhemoglobin value of '18' alongside the label 'CO', suggesting a case of carbon monoxide exposure. Flanking the screen are vertical bar graphs for signal strength (SIQ) and plethysmographic variability. The interface includes tactile control buttons for power, navigation (ENTER, NEXT), and display settings. A reusable finger sensor clip is connected via a cord, illustrating the bedside application for rapid screening in emergency medicine, pre-hospital care, and occupational health settings. This tool is critical for the early detection of carbon monoxide poisoning, which can present with non-specific clinical symptoms.

This forensic clinical photograph series documents post-mortem external examination findings in a case of carbon monoxide poisoning. Images A and B illustrate the characteristic cherry-red livor mortis (hypostasis) on the torso. Image A shows a distinct, bright pinkish-red confluent discoloration along the left lateral thoracic and abdominal regions. Image B displays a similar cherry-red distribution across the posterior aspect of the back, exhibiting a patchy, reticulated pattern where pressure from the underlying surface has caused blanched areas. These findings are pathognomonic for high levels of carboxyhemoglobin. Image C is a close-up of the right hand, showing blackish soot incrustations deposited under the fingernails and within the subungual spaces, indicative of proximity to a fire or smoke source. The skin on the dorsal aspect of the hand appears wrinkled and is being manipulated by a gloved examiner to demonstrate texture. These visual markers are critical in forensic medicine for diagnosing lethal carbon monoxide toxicity and understanding the environmental circumstances surrounding the death.

This pathophysiology diagram illustrates the mechanism of carbon monoxide (CO) mediated inhibition of the intrinsic apoptosis pathway. Panel (a) shows the standard intrinsic pathway: Cytochrome c (cyt c) functions within the mitochondrial intermembrane space, interacting with the electron transport chain (Complexes I-V) and cardiolipin (CL) on the inner mitochondrial membrane. Peroxidation of CL to hydroperoxycardiolipin (CL-OOH) facilitates cyt c release through Bax pores in the outer mitochondrial membrane. Once in the cytosol, cyt c binds with APAF1 and Caspase-9 to form the apoptosome, activating Caspase-3 and triggering apoptosis. Panel (b) depicts the inhibitory mechanism of sub-clinical CO. CO molecules diffuse across the outer membrane into the intermembrane space and bind to the cytochrome c-cardiolipin complex (CL-cyt c). This binding inhibits cyt c peroxidase activity, preventing CL oxidation and the subsequent release of cyt c into the cytosol. The diagram demonstrates how CO blocks the upstream signals required for apoptosome assembly and caspase activation, thereby suppressing programmed cell death.

A two-part pathophysiology diagram (labeled a and b) illustrating the chemical sensing mechanism of an Aluminum (Al)-doped Zinc Oxide (ZnO) nanorod-coated microcantilever surface for Carbon Monoxide (CO) detection. Panel (a) depicts the initial state under ambient humidity where the ZnO surface is heavily coated with adsorbed H2O molecules (light blue) and dissociated H2O (light gray), alongside Al-doping atoms (red). As CO gas molecules (dark blue) approach the surface, a competitive desorption process is initiated, shown by an arrow representing water vapor leaving the slab. Panel (b) shows the displaced state where undissociated water molecules have been largely replaced by CO molecules, which preferentially adsorb at the Al-doped sites. The educational focus is on the mass-change detection principle: because the total mass of adsorbed CO is lighter than the displaced water vapor layers, the microcantilever's resonant frequency increases, allowing for sensitive environmental gas monitoring and clinical toxicology applications.

This composite educational graphic illustrates the development and efficacy of carbon monoxide (CO)-releasing nanoparticles (CPHs) for the treatment of osteoarthritis (OA). Section (a) is a pathophysiology diagram showing the mechanism of CO-releasing nanoparticles: they target activated macrophages, consume intracellular hydrogen peroxide (H2O2), and release CO to inhibit pro-inflammatory pathways (p38 MAPK, NF-κB) and suppress cytokines (IL-1β, IL-6, TNF-α). Section (b) displays diagnostic imaging via reconstructed micro-CT of rodent knee joints across various experimental groups: Normal, OA (showing significant subchondral bone degradation), Dex-p (dexamethasone), and escalating doses of CPH (CPH-1 to CPH-2). The images demonstrate a dose-dependent recovery of bone density and joint surface integrity in CPH-treated groups. Section (c) provides histopathological comparison charts using Hematoxylin and Eosin (H&E) and Safranin O staining. In the OA group, there is marked cartilage erosion and proteoglycan loss (decreased orange/red staining). Treatment with CPH-2 shows significant chondroprotection, characterized by restored cartilage thickness, improved cellular organization, and intense Safranin O staining, indicating successful cartilage regeneration.

**Imaging Modality:** Magnetic Resonance Imaging (MRI), T1-weighted sequence. **Anatomical Region:** Coronal section of the brain at the level of the basal ganglia and lateral ventricles. **Observed Pathology:** Carbon monoxide (CO) poisoning. **Characteristic Visual Features:** The image demonstrates bilateral, relatively symmetric areas of signal abnormality localized to the globus pallidus. These lesions appear as well-defined, focal regions of hypointensity on this T1-weighted sequence. The surrounding white matter and cortical structures appear grossly preserved, though there is a subtle suggestion of generalized cerebral volume loss. **Clinical Context:** Bilateral necrosis or signal alteration of the globus pallidus is a hallmark radiologic finding of acute or subacute carbon monoxide toxicity, resulting from the high metabolic demand of these nuclei and the carboxyhemoglobin-induced hypoxic-ischemic insult. **Key Diagnostic Features:** Symmetric involvement of the globus pallidus is a classic "signature" finding that helps differentiate CO poisoning from other causes of basal ganglia lesions, such as Wilson's disease, cyanide poisoning, or Leigh syndrome.

This pathophysiology diagram illustrates the mechanism of carbon monoxide (CO) mediated inhibition of the intrinsic apoptosis pathway. Panel (a) shows the standard intrinsic pathway: Cytochrome c (cyt c) functions within the mitochondrial intermembrane space, interacting with the electron transport chain (Complexes I-V) and cardiolipin (CL) on the inner mitochondrial membrane. Peroxidation of CL to hydroperoxycardiolipin (CL-OOH) facilitates cyt c release through Bax pores in the outer mitochondrial membrane. Once in the cytosol, cyt c binds with APAF1 and Caspase-9 to form the apoptosome, activating Caspase-3 and triggering apoptosis. Panel (b) depicts the inhibitory mechanism of sub-clinical CO. CO molecules diffuse across the outer membrane into the intermembrane space and bind to the cytochrome c-cardiolipin complex (CL-cyt c). This binding inhibits cyt c peroxidase activity, preventing CL oxidation and the subsequent release of cyt c into the cytosol. The diagram demonstrates how CO blocks the upstream signals required for apoptosome assembly and caspase activation, thereby suppressing programmed cell death.

This diagnostic comparison uses axial brain MRI sequences to illustrate neuroimaging findings in acute carbon monoxide (CO) poisoning. The top row (A-D) shows a healthy control subject, while the bottom row (E-H) represents a patient four days after CO exposure. The imaging modalities include Fluid-Attenuated Inversion Recovery (FLAIR; A, E), T2-weighted imaging (B, F), Fractional Anisotropy (FA) maps (C, G), and Mean Kurtosis (MK) maps (D, H). While conventional FLAIR, T2, and FA maps appear unremarkable and show no visible pathology in the acute phase, the MK map (H) reveals a distinct region of hypointensity in the genu of the corpus callosum (indicated by a black arrow), reflecting early microstructural white matter changes. Additionally, white arrows highlight that the MK maps (D, H) provide superior anatomical delineation between the caudate nuclei and lateral ventricles compared to FA maps (C, G), due to reduced sensitivity to cerebrospinal fluid (CSF) contamination. This educational comparison demonstrates the increased sensitivity of Diffusional Kurtosis Imaging (DKI) in detecting acute toxic-ischemic encephalopathy.

This diagnostic image grid displays serial axial brain magnetic resonance imaging (MRI) of a patient following carbon monoxide (CO) poisoning. The grid compares two modalities—Fluid-Attenuated Inversion Recovery (FLAIR) and Diffusion-Weighted Imaging (DWI)—across four time points: Day 2 (A), Day 40 (B), Day 126 (C), and Day 390 (D). Key findings include: - Day 2: Symmetric hyperintense lesions are prominent in the bilateral globus pallidus, characteristic of acute CO-induced necrosis. - Day 40: Development of extensive, symmetric hyperintensities in the subcortical and periventricular white matter, representing delayed neuropsychiatric syndrome (DNS) or leukoencephalopathy. - Day 126: Significant interval reduction in the intensity and extent of the white matter lesions. - Day 390: Resolution of the white matter abnormalities, while the bilateral globus pallidus lesions persist as chronic findings. The comparison demonstrates the temporal evolution of CO-induced brain injury, showing the transition from acute basal ganglia damage to delayed white matter involvement and eventual partial radiological recovery. This series is an educational example of neurotoxicology and metabolic encephalopathy.

A comparative diagnostic imaging panel showing axial brain MRI slices from two patients with acute carbon monoxide (CO) poisoning (A-D) and one healthy control (E-F). The panel contrasts structural T2-weighted imaging (T2WI) with functional Glutamate Chemical Exchange Saturation Transfer (GluCEST) mapping. Subfigures A and C (T2WI) reveal bilateral hyperintensities in the globus pallidus, a characteristic sign of CO-induced hypoxic-ischemic injury. Subfigures B and D display the corresponding GluCEST maps, where a color-coded scale (ranging from -0.25 to 0.25) indicates higher glutamate levels in shades of yellow and red. These maps demonstrate markedly elevated GluCEST signals in the basal ganglia and cerebral white matter of the patients compared to the control. In contrast, subfigures E (T2WI) and F (GluCEST) show normal neuroanatomy and a uniform, low-intensity glutamate distribution. This educational comparison highlights the utility of metabolic CEST imaging in detecting neurochemical alterations that correlate with structural damage in toxic encephalopathy.

This Comparison Chart features two side-by-side axial non-contrast CT scans of the chest demonstrating the progression of pulmonary complications in a patient with acute carbon monoxide poisoning and aspiration pneumonia. Image (a), taken at admission, shows diffuse bilateral thickening of the lung texture with extensive ground-glass opacities (GGO) and multifocal, high-density nodular and patchy shadows. These abnormalities exhibit fuzzy margins and are predominantly distributed in the inner and middle lung zones, particularly in the upper lobes, resulting in significantly decreased overall pulmonary light transmittance. Image (b), obtained 3 days post-admission, reveals a marked radiological improvement. While some residual patchy shadows and ground-glass opacities persist, the density and extent of the pulmonary edema and inflammatory infiltrates have substantially diminished. This series illustrates the acute parenchymal changes and rapid initial recovery typical of CO-induced toxic pulmonary edema when managed with supportive care. The content is suitable for intermediate to advanced medical students and radiology residents focusing on emergency medicine and pulmonary pathology.

This diagnostic image shows a side-by-side comparison of two longitudinal bipolar montage electroencephalograms (EEG) from a pediatric patient following carbon monoxide (CO) poisoning, illustrating the progression of encephalopathy. Panel A (day 6 post-exposure) displays severe diffuse slowing characterized by high-amplitude delta wave activity (<4 Hz) across all leads, with a lack of normal posterior dominant rhythm and absence of focal or epileptiform discharges. Panel B (day 10 post-exposure) demonstrates clinical and neurophysiological improvement, showing a transition to lower-amplitude, higher-frequency theta waves (4–7 Hz). While some residual delta activity remains, the overall background activity reflects a recovering cortical state. Both panels include a single-lead EKG rhythm strip at the bottom for cardiac monitoring. This comparison serves as a diagnostic tool for monitoring neurological recovery and the severity of toxic-ischemic brain injury in acute CO poisoning cases.